Source: Freerepublic.com
Novel medicines can’t be treated in the same zero-sum way as semiconductors or electric vehicles, where one competitor’s win comes at the expense of the other, says Juliana Liu for Bloomberg Opinion.As Washington and Beijing tussle for dominance in frontier t…